Home » Blog » Transitioning From Nonspecific Therapy To Berotralstat In Hereditary Angioedema Type I: Real World Data From Three Familial Patients.
Transitioning From Nonspecific Therapy To Berotralstat In Hereditary Angioedema Type I: Real World Data From Three Familial Patients.
2 Views
SaveSavedRemoved 0
Berotralstat, a extremely selective kallikrein inhibitor, is accredited as a first-line, once-daily oral long-term prophylaxis (LTP) for hereditary angioedema (HAE). This case collection goals to explain initiation and monitoring of berotralstat remedy in a real-world setting for a household with HAE, following worldwide pointers.
Trending Merchandise
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$25.00
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$29.71
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$32.99
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$13.99
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$17.99
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$7.85
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$8.83
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$45.40
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$9.99
Added to wishlistRemoved from wishlist 0
Carlyle Cat’s Claw Capsules 1000mg | 180 Count | Uncaria Tomentosa | Non-GMO, Gluten Free Supplement
Added to wishlistRemoved from wishlist 0
$15.28